Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen

Clinical Cancer Research

Volumn 7, Issue 9, 2001, Pages 2731-2738

  Ghadersohi, A ^a   Sood, A K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TUMOR ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BREAST TUMOR; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA LIBRARY; FEMALE; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; BREAST; BREAST NEOPLASMS; CYTOCHROME B GROUP; DATABASES, FACTUAL; DNA, COMPLEMENTARY; EXPRESSED SEQUENCE TAGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GENOME, HUMAN; HUMANS; MALE; MYOSIN LIGHT CHAINS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034802736     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. B-cell monoclonal antibodies and their use in clinical oncology
2. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells
3. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer
4. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines
5. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer
6. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: Characterization of tissue-specific ING1 transcripts and a homologue gene
7. Cancer vaccine: Problems and promises
8. The cancer genome anatomy project
9. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression
10. An expressed-sequence-tag database of the human prostate: Sequence analysis of 1168 cDNA clones
11. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain
12. Cytochrome b56l can be detected in many neuroendocrine tissues using a specific monoclonal antibody
13. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
14. Cancer gene discovery using digital differential display
15. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors
16. Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells
17. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA
18. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer
19. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR
20. Minimal residual disease in breast cancer
21. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: Correlation with established prognostic parameters
22. Approaches for immunotherapy of lymphomas
23. Targeted cytokines for cancer immunotherapy
24. Therapeutic vaccination for cancer
25. 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy
26. Immunoselection in vivo: Independent loss of MHC Class I and melanocyte differentiation antigen expression in metastatic melanoma
27. Tumor escapes from immune recognition. Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen
28. β2-microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma
29. Peptide vaccination in clinical oncology
30. Tumor escape from immune recognition: Loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6